A Single-Center, Evaluator-blind, Randomized Control Study to Assess the Effectiveness and Safety of Collagen Membrane (FormaAid®) in the Treatment of Periodontal Regeneration

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this clinical trial is to evaluate clinically and radiographically effectiveness and products safety of the collagen membrane (FormaAid®) in the treatment of periodontal regeneration using guided tissue regeneration (GTR) performed by the trained periodontists. The main question it aims to answer are: * The difference of periodontal status: clinical attachment level (CAL), periodontal pocket depth (PPD), gingival recession (GR), gingival Index (GI) and plaque index (PI). * The difference of intrabony defect height. * The difference of gingival tissue thickness and gingival tissue volume. * The incidences of safety indicators. Participants will be randomized into either experiment group or control group, undergo guided tissue regeneration (GTR) surgery at week 1, and re-visited on week 3, 5, 13 and 27 after the GTR surgery. Researchers will compare if the test product is non-inferior to Bio-Gide.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 70
Healthy Volunteers: f
View:

• Age between 18 70 years old, male or female

• Non current smoker: A person who has not smoked more than 100 cigarettes from the past to the present and has not smoked in the last 30 days.

• Patients who have decided to pay at their own expense and require guided tissue regeneration (GTR) for periodontal regeneration

• The defect morphology of intrabony defects is 2 or 3 wall intrabony defect.

• Periodontal pocket depth ≥ 5mm (probing periodontal depth, PPD, distance from gingival margin to the bottom of the defect).

• The height of the bone defect in the X ray image is ≥ 3mm (according to the X ray film intraosseous defect)

• The diagnosis of periodontal disease is stage III with either grade B or C.

• Patients who are willing to adhere to the study protocol and sign the informed consent form.

• Willing to accept evaluation during the trial period and return to clinic and treatment.

• Not a person subject to a sentence of guardianship or subject to judicial guardians.

Locations
Other Locations
Taiwan
Tri-Service General Hospital
RECRUITING
Taipei
Contact Information
Primary
LiRong Chen
lirong.chen@mbi.com.tw
+88633287222
Time Frame
Start Date: 2024-07-30
Estimated Completion Date: 2025-10-31
Participants
Target number of participants: 60
Treatments
Experimental: FormaAid group
Patients with intrabony defects are randomly assigned to receive either FormaAid collagen membrane or Geistlich Bio-Gide (control)before the GTR. And then treated with GTR surgery, the surgical procedure involves a full-thickness flap, the affected area is cleaned, and the damaged or diseased tissue may be removed. The allograft will be then placed into the defect and the collagen membrane is then trimmed and adapted over the defect. After all the treatment is done, 5-0 nylon suture will be used for the flap closure.
Active_comparator: Bio-Gide group
Patients with intrabony defects are randomly assigned to receive either FormaAid collagen membrane or Geistlich Bio-Gide (control)before the GTR. And then treated with GTR surgery, the surgical procedure involves a full-thickness flap, the affected area is cleaned, and the damaged or diseased tissue may be removed. The allograft will be then placed into the defect and the collagen membrane is then trimmed and adapted over the defect. After all the treatment is done, 5-0 nylon suture will be used for the flap closure.
Related Therapeutic Areas
Sponsors
Leads: Maxigen Biotech Inc.
Collaborators: Tri-Service General Hospital

This content was sourced from clinicaltrials.gov